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Objectives: this study compared the efficiency of electroporation and synthetic amphiphiles (SAINT-2pp/DOPE) in
transfecting small numbers of human endothelial cells.
Methods and results: optimal transfection conditions were tested and appeared to be 400 V and 960 lF for electroporation
and a 10:1 ratio for concentrations of SAINT-2pp/DOPE: plasmid. Using these conditions, cell concentrations were
lowered step-wise and we were able to transfect as few as one thousand cells with both methods. For detection of
transfection of a small number of cells a sensitive assay was needed (Luciferase). A plasmid containing the neomycin
resistance gene was used to determine the transfection rate expressed in colony forming units by counting colonies after
selection. At low plasmid concentrations this transfection rate was within the same range for both electroporation and
SAINT-2pp/DOPE transfection. Fluorescent in situ hybridisation of metaphase chromosomes of transfected endothelial
cells using the plasmid as a probe showed that stable integration was possible with both methods.
Conclusions: electroporation and a synthetic amphiphile, SAINT-2pp, provide the possibility of transfecting small numbers
of cells resulting in stable integration of low plasmid concentrations. The availability of this technology is important in
order to obtain functional endothelial cell lines from various human blood vessels for research purposes.
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Introduction precipitation, DEAE-dextran mediated transfection,
lipofection and electroporation. For EC, calcium phos-
Various vascular disorders, such as deep vein throm- phate and DEAE-dextran are less effective.1–7 As for
lipofection of EC, varying results have been reported,bosis, myocardial infarction and graft occlusion, are
related to injury or functional abnormalities of endo- depending on the cationic lipid used.1–5,7,8 Successful
attempts have been made to improve these methodsthelial cells (EC). In order to investigate the role of EC
it may be valuable to culture EC from blood vessels by using strontium phosphate instead of calcium phos-
phate,3 or Apo E-mediated lipofection.5 Nevertheless,in which these disorders actually occur. However,
these vessels cannot easily be obtained and only a small electroporation is still the most efficient transfection
method for EC, in spite of the low cell viability.3,4,7–12amount of material will be available. Furthermore,
cultures of human EC have a limited life span and SAINT-2pp is a novel synthetic amphiphile, the syn-
thesis of which was recently reported.13 It appeared tolose their original functions during culture, so it would
be useful to produce cell lines with an infinite life be less toxic than other amphiphiles used for
lipofection.14 Moreover, this compound, mixed withspan which have preserved their original haemostatic
functions. In this study we used human umbilical vein DOPE (1:1), transfects cells with an efficiency of an
order of magnitude better than that obtained for li-endothelial cells (HUVEC) as a model to transfect
effectively a minimal number of EC. pofection, which has been most commonly used for
transfection thus far. In this study we comparedCommonly used non-infectious methods for trans-
fection of mammalian cells are calcium phosphate SAINT-2pp/DOPE mediated lipofection with electro-
poration in their efficiency to transfect small numbers
* Please address all correspondence to: M. H. J. Ruiters, Centre for of HUVEC.
Biomedical Technology, University of Groningen, PO Box 145, 9700
AC Groningen, The Netherlands.
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Materials and Methods Electroporation
Materials HUVEC were transfected by electroporation with a
Gene Pulser (BIO-RAD) at 200–400 V and 250–960 lF
Chymotrypsin and gelatin were obtained from Sigma (n=1). Electroporations were performed with 106 cells
and 10 lg pCAT in 600 ll culture medium in a 0.4 cmChemical Co (U.S.A.). Tryptin/EDTA, RPMI 1640 and
L-glutamine came from Gibco (Scotland). Heparin was cuvette. After electroporation cells were transferred
into 100 mm cell culture dishes with 10 ml of cultureused from Leo Pharmaceutical Products B.V. (The
Netherlands). Streptomycin was obtained from Ra- medium. Optimal voltage and capacity were used for
further experiments. Cell concentrations were lowereddiumfarma-Fisiopharma (Italy) and penicillin from Ya-
manouchi Pharma B.V. (The Netherlands). Tissue step-wise from 5·106 to 102 cells per electroporation
(n=1) and a more sensitive reporter system was usedculture flasks (25, 75 and 165 cm2), 100 mm cell culture
dishes, 6-well clusters and cell scrapers were pur- (pCMVLuc). When fewer than 105 cells were electro-
porated, they were transferred into 6-well clusters withchased from Costar (U.S.A.).
Reporter plasmids (pCAT control vector and 2 ml of culture medium.
pCMVLuc), cell lysis buffers and luciferase substrate
came from Promega (U.S.A.). Electroporation cuvettes
were obtained from BIO-RAD (U.S.A.). SAINT-2pp was
SAINT-2pp/DOPE transfectionsynthesised as previously described.13 DOPE was pur-
chased from Avanti Polar Lipids Inc. (U.S.A.). 14C-
The day before transfection, 2·105 HUVEC were trans-labeled chloramphenicol was obtained from Amer-
ferred into 6-well clusters. The next day the cells weresham (U.S.A.), n-butyryl-CoA from Fluka (Swit-
washed twice with Hepes-buffered saline (HBS; 20 mMzerland) and mixed xylenes from Sigma-Aldrich (The
Hepes, 150 mM NaCl, pH 7.4). Amounts of 10–50 nmolNetherlands). Scintillation fluid (ultima gold XR) came
SAINT-2pp/DOPE were mixed with 1 lg pCMVLucfrom Packard (U.S.A.). Thin-layer plates were pur-
(ratios 10:1 to 50:1) in 1 ml of HBS and added to thechased from Merck (Germany) and radiographic films
cells (n=1). After incubation for 4 h at 37 °C, 1 ml(Kodak X-omat) from Sigma Chemical Co (U.S.A.).
culture medium was added for further incubationpMC1NeoPolyA was used from Stratagene (U.S.A.).
overnight. The optimal ratio was used in combinationGeneticin (G418) was obtained from Boehringer Mann-
with cell concentrations lowered step-wise from 2·105heim (Germany).
to 102 cells per transfection (n=1).
Cell culture
Endothelial cells were isolated from human umbilical CAT assay
veins (HUVEC) according to the method of Jaffe et al.,15
except that 0.1 mg/ml chymotrypsin resuspended in The following procedure was used to measure chlor-
amphenicol acetyl transferase (CAT) activity.18 Twophosphate-buffered saline (PBS; 140 mM NaCl, 9.0 mM
Na2HPO4 and 1.3 mM NaH2PO4) was used instead of days after transfection, cell extracts were made with
reporter lysis buffer and cell remnants were removedcollagenase. This modification provides a higher yield
of EC with fewer contaminating smooth muscle cells.16 by centrifugation. The supernatant was incubated for
4.5 h with 75 nCi 14C-labeled chloramphenicol andPrimary isolates were cultured in 1% gelatin-precoated
25 cm2 tissue culture flasks at 37 °C under 5% CO2/ 25 lg n-butyryl-CoA in Tris-buffer (0.25 M, pH 8.0) at
37 °C.95% air. The culture medium consisted of RPMI 1640
supplemented with 20% heat-inactivated human For liquid scintillation counting (LSC), mixed xy-
lenes were added. The organic phase was transferredserum, 2 mM L-glutamine, 5 U/ml heparin, 50 lg/ml
EC growth factor supplement extracted from bovine to a scintillation vial filled with scintillation fluid and
measured in a liquid scintillation counter (Packard).hypothalamus,17 100 lg/ml streptomycin, and 100 U/
ml penicillin. After attaining confluence, cells were The amount of radioactivity expressed in dis-
integrations per minute (dpm) correlates with the CATdetached from the surface by trypsin/EDTA (0.5/
0.2 mg/ml) and split at a 1:3 ratio. Cells were counted activity.
For thin layer chromatography (TLC), ethyl acetatewith a Coulter counter and used for experiments up
to passage five; no differences in transfection rate were was added. The organic phase was dried and in a
small volume of ethyl acetate the samples were appliedobserved between these passages.
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to the thin-layer plate. After chromatography with
chloroform/methanol (19:1), CAT activity was visu-
alised by the intensity of black spots on a radiographic
film.
Luciferase assay
To measure luciferase activity,19 cell extracts were made
with cell culture lysis reagent one day after transfection
and cell remnants were removed by centrifugation.
Luciferase assay substrate was added to the super-
natant and luminescence was measured (Lucy-1, An-
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thos). The amount of luminescence expressed in
relative light units (rlu) correlates with the luciferase Fig. 1. Transfection by electroporation with pCAT at different volt-
ages and capacities. Electroporation of 106 HUVEC with 10 lg pCATactivity.
in 600 ll culture medium in a 0.4 cm cuvette at 200, 250, 300, 350
and 400 V; and 250, 500 and 960 lF (n=1). CAT activity is expressed
in dpm. (F) 200 V; (D) 250 V; (E) 300 V; (G) 350 V; (Ú) 400 V.
Statistics
Transfection rate
The results shown in Fig. 6 are presented as mean
Electroporation and SAINT-2pp/DOPE transfection of values and standard deviations of at least four ex-
105 HUVEC were performed with various con- periments. To compare the CFU-values at different
centrations of pMC1NeoPolyA (n[4). One day after concentrations of plasmid, the unpaired t-test was
transfection, cells were provided with fresh culture used.
medium; on the second day they were transferred to
a larger surface. G418 was added at a concentration
of 400 lg/ml for at least 8 days. Cell doubling of each
Resultstransfected cell which survived the process caused the
formation of one colony. These colonies were counted
To determine optimal electroporation conditions forby light microscopy and the transfection rate was
HUVEC, five different voltages (200, 250, 300, 350 andexpressed in colony-forming units (1 CFU=formation
400 V) were used at three different capacities (250, 500of one colony when 1 lg plasmid and 105 EC were
and 960 lF). Figure 1 shows that an increase of voltageused).
and capacity resulted in an increase of CAT activity.
HUVEC even survived 400 V and 960 lF, which res-
ulted in the highest CAT activity. These optimal con-
ditions were used to determine the minimum amount
of HUVEC still expressing CAT activity after elec-Fluorescent in situ hybridisation
troporation. Figure 2 shows that decreasing the amount
of cells resulted in a decreased CAT activity. At 105EC cultured after transfection with pMC1NeoPolyA
were detached from the surface of the culture flask HUVEC almost no CAT activity was left.
SAINT-2pp/DOPE transfections of HUVEC resultedby trypsin/EDTA, subjected to hypotonic treatment
with 0.025 M KCl, fixed in methanol–acetic-acid, 3:1 in CAT activities fluctuating around background val-
ues, as measured with LSC (results not shown). TLC(v/v) and dropped onto slides according to standard
procedures for the preparation of metaphase spreads. was used to visualise the product formed by the CAT
enzyme. However, no black spots could be detectedFluorescent in situ hybridisation (FISH) was performed
on the preparations according to standard laboratory on the radiographic film in case of SAINT-2pp/DOPE
transfections. Even for electroporation, when the high-protocols using as a probe the biotinylated plasmid
pMC1NeoPolyA. Integration of the plasmid was as- est CAT activity measured by LSC was used, only a
very weak spot was present after TLC (results notsessed by fluorescence microscopy.
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Fig. 2. Transfection by electroporation with pCAT and different Fig. 4. Comparison of different concentrations SAINT-2pp/DOPE.
Transfection of 2·105 HUVEC in a 6-well cluster with 10, 20, 30,amount of cells. Electroporation of 5·106, 3·106, 106, 105, 104, 103
and 102 HUVEC with 10 lg pCAT in 600 ll culture medium in a 40 and 50 nmol SAINT-2pp/DOPE and 1 lg pCMVLuc (ratios 10:1
to 50:1) in 1 ml HBS for 4 h (n=1). Luciferase activity is expressed0.4 cm cuvette at 960 lF and 400 V (n=1). CAT activity is expressed
in dpm. in rlu.
shown). Therefore a switch was made to a more sens-
itive reporter system (pCMVLuc).
Electroporation with decreasing amounts of HUVEC
was repeated with pCMVLuc instead of pCAT. Figure
3 shows a decrease of luciferase activity when fewer
cells were electroporated. Compared with the CAT
assay, the luciferase assay was a hundred-fold more
sensitive. At 103 HUVEC there was still some activity
present. In case of SAINT-2pp/DOPE transfections, lu-
ciferase activities were much higher than background
values. Figure 4 shows that an increasing concentration
of SAINT-2pp/DOPE at a constant plasmid con-
centration resulted in a decreased luciferase activity.
At the conditions tested, the highest activity was found
when 10 nmol/ml was used at a plasmid concentration
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of 1 lg/ml (ratio 10:1). This ratio was used to determine
Fig. 5. SAINT-2pp/DOPE transfection with pCMVLuc and different
the minimum amount of HUVEC still expressing lu- amount of cells. Transfection of 2·105, 105, 104, 103 and 102 HUVEC
in a 6-well cluster with 10 nmol SAINT-2pp/DOPE and 1 lgciferase activity after SAINT-2pp/DOPE transfection.
pCMVLuc in 1 ml HBS for 4 h (n=1). Luciferase activity is expressed
in rlu.
Figure 5 shows that a decreasing amount of cells
resulted in a decreased luciferase activity. Again, even
with only 103 HUVEC activity was present. Figures
1–5 show the results of one representative experiment.
More experiments were performed, but in transient
transfection assays the absolute values on the y-axis
cannot be compared between different experiments.
To investigate whether either transfection method
1000
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has an advantage over the other in forming colonies,
Fig. 3. Transfection by electroporation with pCMVLuc and different pMC1NeoPolyA was used instead of pCMVLuc. More
amount of cells. Electroporation of 106, 105, 104, 103 and 102 HUVEC colonies were counted with a higher plasmid con-with 10 lg pCMVLuc in 600 ll culture medium in a 0.4 cm cuvette
at 960 lF and 400 V (n=1). Luciferase activity is expressed in rlu. centration for electroporation was used. Although, at
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Discussion
Both electroporation and lipofection with SAINT-2pp/
DOPE appeared to be efficient transfection methods
for EC. Electroporation should be performed at 400 V
and 960 lF and similar optimal conditions have been
reported before by Kotnis et al.11 In the case of SAINT-
2pp/DOPE transfection the ratio 10:1 (nmol SAINT-
2pp/DOPE:lg plasmid) should be used instead of
higher ratios, in order to get better transfection. Syn-
thetic amphiphile mediated transfections are usually
performed with 1 lg of plasmid13,14 and electro-
porations with up to 50 lg. This study therefore
started with 1 lg for SAINT-2pp/DOPE transfection
and 10 lg for electroporation. When we used a sens-10
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itive transient expression assay (luciferase instead of
CAT), we were able to detect activity with both trans-Fig. 6. Comparison of two transfection methods at different plasmid
concentrations. Electroporation of 105 HUVEC with 1, 2.5, 5, 10 and fection methods in as few as one thousand EC. This
25 lg pMC1NeoPolyA. SAINT-2pp/DOPE transfection of 105 HUVEC is important for the production of functional endo-
with 1, 2.5, 5 and 10 lg pMC1NeoPolyA. Optimal transfection
thelial cell lines from various human blood vessels,coditions were used and colonies were counted after selection with
G418. Transfection rate is expressed in colony-forming units (CFU= because only small amounts of material are available.
amount of colonies per lg plasmid per 105 EC)–s.d. (n[4). (F) If isolation results in only a few EC, transfection can
Electr; (D) SAINT-2.
be performed shortly after isolation, when it can be
assumed that most of the specific EC functions are
still present.
The plasmids used contained the reporter genes
chloramphenicol acetyltransferase or luciferase, which
cannot be used to determine the percentage of trans-
fected cells. As production of cell lines requires the
outgrowth of colonies, both transfection methods were
also compared using the neomycin resistance gene.
When only a few cells are available and there is no
limitation for the use of high plasmid concentrations,
electroporation provides for the highest yield of col-
onies. At low plasmid concentrations the transfection
rate expressed in CFU was within the same range.
FISH of the plasmid used for transfection of EC on
Fig. 7. FISH of the plasmid used for transfection of EC on metaphase metaphase chromosomes of transfected EC was per-
chromosomes of transfected EC. Specific hybridisation on a chro- formed after long-term culture and showed that in-mosome was detected with fluorescein-avidin (yellow green) in
tegration of the plasmid occurred after transfection incombination with goat anti-avidin. Total DNA was stained with
propidium iodide (red). both ways. So SAINT-2pp/DOPE mediated lipofection
appeared to be as effective as electroporation.
low plasmid concentrations (1 and 2.5 lg) Figure 6 In conclusion, this study shows that as few as 1000
shows a higher CFU (significant, p<0.05). In case of EC can be transfected by electroporation and with
SAINT-2pp/DOPE transfection colonies were counted SAINT-2pp/DOPE. Both methods result in stable in-
only at low plasmid concentrations. At 5 and 10 lg tegration of the plasmid and at low plasmid con-
plasmid, the transfection mixture, which also con- centrations, they also have the same transfection rate.
tained 50 and 100 nmol synthetic amphiphiles (ratio Transfection of small numbers of EC shortly after
10:1), became toxic for the cells.13,14 Figure 6 shows isolation will reduce the risk of losing original func-
that the CFU for both methods was about the same at tions before transfection. This is important to obtain
low concentrations of plasmid (not significant, p<0.1). functional endothelial cell lines from various human
Figure 7 shows, by using FISH, that integration of the blood vessels for research purposes such as thrombosis
plasmid occurred in one chromosome per transfected in vascular diseases. Transfections of adult venous and
arterial cells are in progress.EC.
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